.

Alogliptin Benzoate Powder Type 2 Diabetes Treatment Drug Medical Grade

» Pharmaceutical » Anti-diabetic Drug » Alogliptin Benzoate Powder Type 2 Diabetes Treatment Drug Medical Grade

Alogliptin Benzoate Powder Type 2 Diabetes Treatment Drug Medical Grade

CATEGORY AND TAGS:
Anti-diabetic Drug , , , , , , , ,
enquiry
  • Specifications

Buy Alogliptin Benzoate Powder Type 2 Diabetes Treatment Drug Medical Grade

 

What is Alogliptin benzoate?

Alogliptin benzoate is the intermediate of Alogliptin, Alogliptin (trade name Nesina in the US and Vipidia in Europe) is an orally administered anti-diabetic drug in the DPP-4 inhibitor class, Like other medications for the treatment of Type 2 diabetes, alogliptin does not decrease the risk of heart attack and stroke. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of causing hypoglycemia, and exhibits relatively modest glucose-lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in patients whose diabetes cannot adequately be controlled with metformin alone.

 

Alogliptin benzoate Specification

Product name Alogliptin benzoate
Synonyms 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate
CAS NO.: 850649-62-6
Molecular Formua C18H21N5O2.C7H6O2
Molecular Weight 461.52
Assay 99.0%min
Appearance White powder
Packaging 100g/bag.1Kg/bag or as demand
Applications Pharmaceutical Intermediates
Status Commercials
Remarks For more details,please contact us

 

Enquiry Form ( we will get back you as soon as possible )

Name:
*
Email:
*
Message:

Verification:
0 + 4 = ?

Maybe you like also